Back to dashboard
CommercialAdministrativeLow impact

08.02.17, Pozelimab-bbfg (Veopoz®)

Independence Blue Cross·Hematology, Oncology, Rheumatology·Pharmacy
Effective date
May 27, 2026
We identified it
Jun 19, 2026
Days to comply
—

Summary

A policy for Pozelimab-bbfg (Veopoz®), a pharmacy benefit drug, has been updated with a reissue effective date of May 27, 2026. This appears to be a future-dated policy reissue for this specialized medication.

Action Required

Action needed
No immediate action required. Monitor for updated policy details as the May 27, 2026 effective date approaches. Billing team should review full policy content when available to understand any changes to coverage, prior authorization, or billing requirements for Pozelimab-bbfg (Veopoz®).

Related policy hubs